Audience: developers and users of ENTITY
Forum: https://github.com/blackmore-technology-group/ENTITY/discussions
Current supported runtime: ENTITY v3.4.3
BTDU component: 3.4.2 unchanged
Frozen external conformance target: ENTITY Protocol 1.0
The ENTITY Community Board is for people who are building, integrating, evaluating, operating or using ENTITY. It is not a marketing, investor-relations or general business-development channel.
Use Q&A when you need help using or implementing ENTITY.
Good topics include installation/setup, identity/authority/rights, SDK/CLI/API usage, BTDU ingestion/reconstruction/recovery, ADAM deterministic state/replay, NIKI reasoning boundaries, passports/evidence/profiles, exchange/market/settlement behavior, and Protocol 1.0 clean-room/conformance questions.
Use General for user/developer discussion that is not yet a defect report or design proposal: onboarding feedback, architecture questions, operating experience, evaluation results, interoperability observations and documentation feedback that needs discussion before a concrete change.
Use Ideas for proposed changes or additions. State the problem, exact target/layer, whether the proposal changes protocol semantics/runtime behavior/documentation/integration only, the authority/rights/evidence/provenance/recovery/economic boundaries involved, and compatibility implications.
An idea is not accepted behavior until it is implemented, reviewed and qualified through the appropriate process.
Use Show and tell for integrations, clean-room experiments, independent/external reproduction, applications using ENTITY, BTDU benchmarks/recovery experiments, standards mappings, tooling, visualizations and deployment experiments.
State clearly whether evidence is BTG-controlled, externally reproduced, independently implemented, experimental or production-qualified.
Announcements are maintainer-posted project updates, releases and major qualification notices. Community members can reply to them.
Use Discussions for questions, ideas, evaluation, design conversation and user/developer experience.
Use Issues for a reproducible defect, specification ambiguity, concrete documentation error, qualification failure or bounded work item that needs tracking.
Use a Pull Request when you have a concrete proposed change with a reviewable diff and test/evidence path.
Use SECURITY.md, not a public Discussion or Issue, for security-sensitive reports that could put users, credentials, keys, private state or deployments at risk.
Every technical discussion should identify the target when it matters:
- ENTITY v3.4.3 — current supported runtime;
- BTDU 3.4.2 — unchanged component used by v3.4.3;
- ENTITY Protocol 1.0 — frozen external conformance target;
- historical v3.4.2 qualification/baselines — historical or inherited unchanged-scope evidence.
Do not silently treat a Protocol 1.0 result as a full v3.4.3 runtime qualification, or historical v3.4.2 evidence as a newly executed v3.4.3 result.
Separate these states when discussing results:
- implemented;
- locally tested;
- BTG-qualified;
- externally reproduced;
- independently implemented/validated;
- upstream accepted;
- economically settled.
One state does not automatically imply another.
Participation is governed by CODE_OF_CONDUCT.md.
Do not post passwords, API keys, signing/recovery keys, credentials, private user/business data, production secrets/private bindings, or exploit details that create avoidable security risk.
Critique implementations, claims and evidence rather than people. Reproducible negative results, counterexamples and incompatible interpretations are welcome.
- Tutorials: https://blackmore-technology-group.github.io/ENTITY-DOCS/tutorials/
- Developer docs: https://blackmore-technology-group.github.io/ENTITY-DOCS/developer/
- Community Board: https://blackmore-technology-group.github.io/ENTITY-DOCS/community/
- Discussions: https://github.com/blackmore-technology-group/ENTITY/discussions
- Issues: https://github.com/blackmore-technology-group/ENTITY/issues
- Contributing: CONTRIBUTING.md
- Security: SECURITY.md